These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 5067529)

  • 41. [Toxic adenoma. Study of 35 cases].
    Barceló Lucerga B; Alcañiz Ferrando J; Ortiz Berrocal J; Salto Hernández L
    Rev Iber Endocrinol; 1971; 18(106):369-83. PubMed ID: 5171341
    [No Abstract]   [Full Text] [Related]  

  • 42. [TSH receptor antibodies in the recurrent goiter after surgical treatment of Graves-Basedow disease].
    Janowska J; Widala E; Zych F
    Pol Merkur Lekarski; 1998 May; 4(23):257-8. PubMed ID: 9825656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of I 131 therapy on SH-group serum levels in patients with toxic goiter].
    Semenov VD
    Med Radiol (Mosk); 1970 Jun; 15(6):58-62. PubMed ID: 5468341
    [No Abstract]   [Full Text] [Related]  

  • 44. [Therapy of endocrine ophthalmopathies].
    Küchle HJ
    Minerva Med; 1972 Feb; 63(14):836-8. PubMed ID: 5066961
    [No Abstract]   [Full Text] [Related]  

  • 45. [Occurrence of TSH receptor antibodies and thyroid microsomal antibodies in Graves-Basedow disease].
    Paunković N; Paunković D
    Med Pregl; 1995; 48(1-2):10-4. PubMed ID: 8657049
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The introduction of I-131 into the thyroid tissue for therapeutic purposes].
    Kevesh EL; Anikandrov BV; Bykhovskaia AM
    Med Radiol (Mosk); 1968 Jan; 13(1):12-5. PubMed ID: 5757476
    [No Abstract]   [Full Text] [Related]  

  • 47. [Rarely encountered association of hyperthyroidism in the form of Graves-Basedow disease with vitiligo].
    Hrycek A; Szwed Z; Badowski R
    Wiad Lek; 1994 Mar; 47(5-6):213-5. PubMed ID: 7941564
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiation doses to patient's relatives following radioiodine therapy.
    Sulaiman BT; Clarke SE
    Med J Malaysia; 1996 Mar; 51(1):131-3. PubMed ID: 10967992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [On the behavior of basophilic granulocytes in Basedow's disease during therapy with I-131].
    Ferlin G; Mantero F
    Acta Isot (Padova); 1968 Oct; 8(2):133-9. PubMed ID: 5761577
    [No Abstract]   [Full Text] [Related]  

  • 50. [The development of adenoma and atypical adenoma following I-131 treatment of thyroid gland diseases].
    Zukschwerdt L; Bay V; Gusek W
    Zentralbl Chir; 1967; 92(26a Pt 1):1319-24. PubMed ID: 5631684
    [No Abstract]   [Full Text] [Related]  

  • 51. Evaluation of the 2nd generation radio-receptional assay for anti-TSH receptor antibodies (TRAb) in autoimmune thyroid diseases. Comparison with 1st generation and anti-thyroperoxidase antibodies (AbTPO).
    Giovanella L; Ceriani L; Garancini S
    Q J Nucl Med; 2001 Mar; 45(1):115-9. PubMed ID: 11456370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radioactive iodine treatment of Graves' disease. Results in 32 children under 16 years of age.
    Crile G; Schumacher OP
    Am J Dis Child; 1965 Nov; 110(5):501-4. PubMed ID: 5897949
    [No Abstract]   [Full Text] [Related]  

  • 53. Humoral mediated immunity in Graves-Basedow ophthalmopathy.
    Adler G; Nauman J; Faryna M; Lewartowska A; Gardas A
    Radiobiol Radiother (Berl); 1987; 28(5):570-4. PubMed ID: 3441605
    [No Abstract]   [Full Text] [Related]  

  • 54. I-131 treatment for toxic diffuse goiter. Analysis of 594 cases treated with repeated doses of 7 millicuries or less.
    Yang HF
    Taiwan Yi Xue Hui Za Zhi; 1971 Feb; 70(2):103-11. PubMed ID: 5281463
    [No Abstract]   [Full Text] [Related]  

  • 55. Implication of excess iodine intake in Graves-Basedow-disease.
    Civantos S; Cancer E; Gorgojo JJ; Cánovas G; Rodríguez A
    Endocrinol Nutr; 2013 May; 60(5):273-5. PubMed ID: 23228509
    [No Abstract]   [Full Text] [Related]  

  • 56. AUTO-IMMUNE DISEASE.
    O'GORMAN P
    Guys Hosp Rep; 1963; 112():402-18. PubMed ID: 14043909
    [No Abstract]   [Full Text] [Related]  

  • 57. The cloistered thyroidologist.
    Bargman GJ; Gardner LI
    Lancet; 1967 Sep; 2(7515):562. PubMed ID: 4166906
    [No Abstract]   [Full Text] [Related]  

  • 58. [Graves-Basedow disease: uncontrolled development].
    Codaccioni JL
    Presse Med; 1991 Apr; 20(16):733-4. PubMed ID: 1828589
    [No Abstract]   [Full Text] [Related]  

  • 59. [Two cases of Basedow disease complicated by acute hepatitis].
    Satoh H; Itoh M; Amada Y; Murata K; Watanabe S; Mukai S; Shoji I; Ohyama S; Shioya T; Ohira H; Kuroda M; Obara K; Kasukawa R
    Nihon Shokakibyo Gakkai Zasshi; 1997 Jun; 94(6):424-8. PubMed ID: 9216224
    [No Abstract]   [Full Text] [Related]  

  • 60. [Immunological status of patients with Basedow-Graves disease treated with radio-iodine].
    Fazakas S; Kiss B; Szegedi G; Petrányi G
    Orv Hetil; 1972 May; 113(22):1281-3. PubMed ID: 5067529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.